MR-proADM as Prognostic Factor of Outcome in COVID-19 Patients.

Paolo CameliElena PordonMiriana d'AlessandroMaria Laura MarziLucrezia GalassoCesare BiuzziLaura Bergantini Elena BargagliSabino ScollettaFederico Franchi

Published in: Biomedicines (2023)

Our data sustain the potential of serum MR-proADM as a reliable prognostic biomarker of hospitalized COVID-19 patients and confirms the utility of the three markers in the management and risk stratification of hospitalized patients. The markers are collected mini-invasively and are quick to analyze and cost-effective.

Keyphrases

prognostic factors
sars cov
contrast enhanced
magnetic resonance
electronic health record
big data
magnetic resonance imaging
human health
machine learning
climate change